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Magnetic resonance imaging (MRI) of patients with cardiac implantable electronic 
devices (CIED) has been associated with risks such as device/lead movement, device 
dysfunction, and lead heating. New technological advancements have made it possible 
for MRI to be safely performed when adhering to an evidence-based protocol; however, 
this practice has not yet been widely adopted. The purpose of this practice-focused 
question project was to examine the safety of MRI as a diagnostic modality for the 
aggregate population of adult patients with MR conditional pacemakers when a nurse-
practitioner-led, evidence-based protocol was used. The Iowa model served as the guide 
for implementation of the program, and the Donabedian framework was used to evaluate 
the program through process, structure, and outcomes. Evidence was obtained through a 
documentation template that served as the procedural record in the electronic health 
record. Demographic information, program fidelity, and manufacturer adherence were 
analyzed through descriptive statistics. Clinical outcomes related to device function were 
measured pre- and post- MRI and analyzed with chi square and paired t-test inferential 
statistics to determine if statistically significant change occurs in the setting of MRI 
scanning. According to data analysis of 34 studies, there were no statistically significant 
changes in lead impedance, pacing thresholds, or patient reported symptoms pre- and 
post- MRI. The pilot program has been recommended for organizational adoption and 
will increase the scope of advanced practice nurses within the organization and provide 
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Section 1: Introduction 
Introduction  
Each year, more than 1 million cardiac implantable electronic devices (CIED) are 
prescribed throughout the world (Zikria, Machinicki, Rhim, Bhatti, & Graham, 2011). 
Approximately 50-75% of patients with CIED will have an indication for magnetic 
resonance imaging (MRI) scanning during their lifetime (Zikria et al., 2011). Historically, 
MRI of patients with CIED has been considered contraindicated, with multiple associated 
risks such as device and/or lead movement, device dysfunction resulting in changes to the 
program parameters and improper function, battery drain, and lead heating causing tissue 
damage (Beinart & Nazarian, 2012; Boilson et al., 2012). However, according to new 
technological advancements, recent studies, and expert opinions, MRI may be safely 
performed when adhering to an evidence-based protocol (Beinart & Nazarian, 2012; 
Boilson et al., 2012; Burke et al., 2010; Gimbel, Passman, & Kanal, 2013; Naehle et al., 
2009; Shenthar et al., 2015). However, this practice has not yet been widely adopted, and 
the presence of a pacemaker remains a relative or absolute contraindication to MRI in 
many practice settings. 
Physician leadership for the electrophysiology and radiology departments at a 
large academic medical center recommended a change in the practice paradigm of the 
organization and an evidence based practice protocol for MRI of MR conditional cardiac 
devices was written and approved for use (see Appendix A). Nurse practitioners with 
expertise in electrophysiology would be responsible for the implementation of this 
protocol using the Iowa model for evidence-based practice. The program was piloted, and 
2 
 
this doctoral project was designed to evaluate the pilot program to determine the safety of 
MRI on MR conditional cardiac devices by examining program fidelity, clinical 
outcomes, and patient symptoms. If the pilot of this protocol is determined to be 
successful, this evidence-based practice has the potential to expand the diagnostic options 
for the growing aggregate population of patients with CIED. 
Problem Statement 
MRI is a growing imaging modality and has become the standard of care for 
diagnosis of many conditions, such as musculoskeletal disorders, soft tissue masses, and 
stroke symptoms. According to Burke et al. (2010), denial of MRI scanning to patients 
based on the presence of CIED creates a health care disparity in which access to optimal 
diagnostic testing is not provided. This disparity may result in delayed or missed 
diagnosis, increased invasive testing, and possible harmful effects from ionizing radiation 
and contrast media. Hence, patients with implanted cardiac pacemakers may receive 
substandard care as a result of the current practice in which pacemaker patients are 
denied MRI as a diagnostic tool. Yamrozik et al. (2015) found that MRI performed on 
patients with CIED provided additional information that confirmed or changed diagnosis 
and/or altered medical management in 76% of neurology patients, 96% of cardiac 
patients, and 80% of musculoskeletal patients.  
The setting for this project was a large, academic medical center that serves as the 
state referral center for tertiary and quaternary care. Until the implementation of the pilot 
program, organizational practice treated the presence of a pacemaker as an absolute 
contraindication to MRI scanning, and no patient with a CIED had access to the 
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diagnostic modality of MRI (see Appendix B). Adoption of an evidence-based protocol 
in which nurse practitioners with expertise in pacemaker programming manage and 
monitor this patient population during MRI scanning increased safe patient access to an 
important diagnostic modality. 
The Institute of Medicine (IOM, 2010) endorsed nurses practicing to the fullest 
extent of their education and licensure as full members of the health care team. 
Expanding the role of the nurse practitioner for the application of an evidence-based 
protocol designed to improve safe patient access to diagnostic testing was an opportunity 
for nurses to make transformations in the delivery of health care. The implementation of 
this nurse-practitioner-led, evidence-based practice protocol required monitoring for 
quality and safety in alignment with the organization’s strategic nursing plan that 
includes improvement of “patient care quality and safety through collaboration with 
physicians and interdisciplinary team members.” The essentials of doctoral practice and 
competencies for acute care nurse practitioners include the integration scientific evidence 
to develop and evaluate new practices using a theoretical approach. Furthermore, I 
examined the use of technology to improve patient care in an aggregate population, safety 
and quality with a systems approach for leadership and management in health care 
systems, and a collaborative multidisciplinary teamwork (American Association of 





The purpose of this quality improvement project was to evaluate the safety of a 
nurse practitioner pilot designed to change the organizational practice paradigm to 
provide MRI as a diagnostic tool to patients with MRI conditional pacemakers in a 
consistently safe manner through the application of an established protocol for FDA 
approved devices.  
The objectives of this quality improvement project included the following: 
1. Monitoring the application of a practice guideline and the clinical 
indicators of device function to evaluate the consistently safe use of MRI 
as a diagnostic tool for patients with implanted MRI conditional 
pacemakers and ICDs.  
2. Data collection and analysis regarding the safety and efficacy of the MRI 
safety protocol for a minimum of 20 patients with implanted cardiac 
pacemakers undergoing MRI over 6 to 12 months.  
3. Presentation of the data to the electrophysiology and radiology team to 
determine if modifications of guidelines are needed.  
4. Dissemination of results within the organization and publication of results. 
These objectives served to answer the practice question: Does the implementation 
of a nurse-practitioner-managed, evidence-based practice protocol result in consistently 




Evidence used to answer the practice question was integral to determining if the 
change in practice paradigm should continue and increase access to a growing diagnostic 
modality for an increasing aggregate population. Increased access to MRI may result in 
more rapid and accurate diagnosis, thus reducing cost, length of stay, and potential harm 
from alternative diagnostic testing.  
Nature of the Doctoral Project 
The purpose of this doctoral project was to focus on quality improvement through 
the evaluation of evidence-based practice using the Iowa model for implementation. In 
this doctoral project, I monitored and evaluated an evidence-based practice guideline 
pilot in the organization and disseminated data regarding the safety and efficacy of a 
nurse-practitioner-administered practice guideline.  
This evaluation was comprised of data collection on patients with MR conditional 
CIED who underwent MRI scanning. The data collected included demographic data, such 
as gender, age, device manufacturer, and MRI site. These data were reported using 
descriptive statistics. Determination if the device manufacturer check list and 
organizational policy was followed via a completed checklist to evaluate program 
fidelity; clinical indicators regarding device function were addressed through the 
measurement of pre and post lead impedance and threshold testing and patient report of 
symptoms experienced during MRI. Inferential statistics were used to examine the pre 
and post data for changes that determined if device function and patient symptoms 
remained stable. These data were collected via a standardized documentation template 
designed as the procedural record within the patient’s electronic medical record.  
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Based upon data analysis that the protocol was followed, CIED function remained 
stable, and patients experienced minimal unpleasant symptoms. The pilot was deemed 
safe and appropriate for permanent practice change, thus resulting in safe access to MRI 
for this aggregate population.  
Significance 
Stakeholders associated with this quality improvement project included hospital 
administration, ordering providers, supervising physicians, nurse practitioners, MRI 
technicians, and the target population of patients with pacemakers in need of MRI 
diagnostic assessment. Successful and safe implementation of a pilot program led to an 
increase in diagnostic access within the organization, which may be generalized as a 
model for the organization’s affiliated sites throughout the state. This also served as an 
opportunity for nurse practitioners in other areas to function at the upper level of their 
education and licensure as a member of the health care team.  
The CIEDs were first used in 1958, and use has expanded to become a standard 
therapy for many cardiac conduction disorders (Udo et al., 2012). According to 
Greenspon et al. (2012), there has been an increase in the number of patients with 
pacemakers since 1993. As of 2009, the average age of a patient receiving a pacemaker is 
75.4 years of age with some variation based on the type of device (Greenspon et al., 
2012). As the age of the pacemaker patient rises, so does the number of comorbid 
conditions in patients. Approximately 50-75% of patients with CIED will have an 
indication for MRI scanning during their lifetime (Zikria et al., 2011). This represents a 
7 
 
significant aggregate population seeking care from multiple providers for a variety of 
conditions.  
Lack of access to MRI may result in delay in diagnosis that can lead to advanced 
disease processes with detrimental effects, such as stroke and oncologic conditions. More 
rapid and accurate diagnosis may lead to decreased morbidity, mortality, and length of 
stay. There are additional costs and risks associated with use of alternative diagnostic 
modalities, such as those associated with ionizing radiation and contrast media; costs that 
may be incurred as a result of false positive or false negative results; and medico-legal 
ramification for providing appropriate diagnostic testing, especially in emergency 
situations and for the safe performance of these exams (Lundquist et al., 2013; Santini, 
Giovanni, & Santini, 2013). 
Medical product safety is a topic identified by Healthy People 2020 (2014) as 
contributing to the 10-year plan for improving the health of all people in the United 
States. Pharmaceuticals and medical devices are included as medical products, and this 
objective focuses on the appropriate use, monitoring, and manufacturing/labeling of these 
products as a goal to decrease adverse events and improve patient outcomes.  
Summary 
Although historically there have been risks such as device malfunction, lead 
heating/movement, and battery drain associated with MRI of patients with pacemakers, 
recent technological advancements, evidence from randomized controlled trials and 
prospective studies, and expert opinion have begun to change the practice paradigm. The 
presence of a pacemaker is no longer an absolute contraindication to MRI as a diagnostic 
8 
 
tool. The implementation of an evidence-based, nurse-practitioner-administered guideline 
through the science of translational research can provide the pacemaker patient 
population with safe access to MRI, thus improving the accuracy and timeliness of many 
diagnoses with decreased invasiveness and exposure to ionizing radiation and contrast 
media while maintaining proper device function. The Iowa model and Donabedian 
framework were used to apply MRI and pacemaker principles and evidence from clinical 
trials to the local context. Pacemaker and MRI concepts, models and theories applied to 
this project, and evidence found in the literature are discussed in detail in the following 
section.   
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Section 2: Background and Context 
Introduction 
There is an increasing cohort of individuals with CIED who are denied access to 
the diagnostic modality of MRI. This quality improvement project was designed to 
evaluate an evidence-based pilot program for MRI of MR conditional CIED and answer 
the following question: Does the implementation of a nurse-practitioner managed practice 
protocol result in consistently safe access to MRI as a diagnostic tool for patients with 
MR conditional pacemakers? In this section, I review the current literature, protocols, and 
the theoretical model used for the evaluation of the pilot program. 
Concepts, Models, and Theories 
The technical concepts of MRI and pacemakers were integral to the formation of 
the protocol used in this project. The Iowa model and Donabedian framework served as 
the guides for implementation and evaluation of the protocol.  
MRI Concepts 
Van der Graaf, Bhagirath, and Gotte (2014) described the function of the MRI as 
follows: The MRI consists of a magnetic, gradient, and radiofrequency transmitter coils 
(Van der Graaf et al., 2014). The magnetic coil generates a strong and constant magnetic 
field. The strength of this magnetic field is described in units called Tesla (Van der Graaf 
et al., 2014). Gradient coils are also present inside the main magnet that are switched on 
and off. The radiofrequency coil produces a magnetic field that delivers energy to 
hydrogen protons. The static and radiofrequency fields create resonance signals that are 
captured by receiving coils and provide detailed image reconstruction of tissue 
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characteristics (Van der Graaf et al., 2014). The amount of energy the individual receives 
is described as specific absorption rate (SAR; Van der Graaf et al., 2014)). The SAR is 
proportional to the static magnetic field strength; hence, a relationship between magnetic 
field strength and scan time determine the amount of energy a patient absorbs. 
MRI and Pacemaker Risks 
There have been 17 MRI-associated deaths in patients since 2007 (Zikria et al., 
2011). Gimbel et al. (2013) reported that due to potential legal action, MRI-associated 
deaths and complications are likely not sufficiently documented. Magnetic resonance 
uses static magnetic, gradient magnetic, and radiofrequency fields in order to generate 
images. All of these fields have the potential to interfere with the function of the 
pacemaker and/or cause tissue damage (Cronin, Mahon, & Wilkhoff, 2012). In vitro, 
MRI examination affects pacemaker function, electrocardiography (EKG) readings, and 
battery life (Zikria et al., 2011).  
Reed switch malfunction. Many CIED have a magnetic reed switch that consists 
of metal strips encapsulated in glass. These magnetic strips switch on or off when 
exposed to a magnetic force (Jacob et al., 2011). Closing of the switch triggers the 
pacemaker to respond by performing programmed functions, such as asynchronous 
pacing or suspending tachycardia therapies, and can also result in battery depletion 
(Jacob et al., 2011). In a systematic review of pacemaker complications associated with 
MRI, Zikria et al. (2011) reported two in vitro and four in vivo studies demonstrating 
reed switch activation when exposed to the static magnetic field of an MRI scanner. 
Some scholars found variation in activation based on positioning within the magnetic 
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field. Vahlhaus et al. (2001) found that all pacemaker patients undergoing MRI had reed 
switch activation with 37.5% having deactivation when positioned in the center of the 
scanner. The reed switch is affected by position to the magnet. Closure of the reed switch 
may lead to asynchronous pacing at a default rate which, originally designed as a safety 
feature, can be harmful if continued for a prolonged period of time (Cronin & Wilkhoff, 
2012).  
Many newer pacemaker models, often referred to as modern pacemakers, have 
alternative technology to replace the reed switch such as giant magnetosensitive resistors 
(GMR), telemetry coils, or Hall-effect sensors (Jacob, 2011). This is one feature change 
found in the design of MR conditional pacemakers.  
Lead heating. The radiofrequency field of the MRI can cause lead tip heating 
resulting in myocardial edema or scarring. This damage can result in loss of pacing 
capture in the cardiac tissue or potential arrhythmias (Beinart & Nazarian, 2012; Boilson 
et al., 2012). Langman, Goldberg, Finn, and Ennis (2011) conducted an in-vitro study to 
determine factors contributing to lead heating and found that lead termination and length 
had the most impact on temperature change. Thus, MRI should not be performed on 
patients with abandoned leads.  
Device dysfunction. Electrical current induction and electromagnetic interference 
have been demonstrated in multiple in vitro and animal studies. Both phenomena occur in 
the MR environment as a result of radiofrequency fields and pulsed gradients (Cronin & 
Wilkhoff, 2012). These electrical disturbances may result in incorrect pacemaker 
diagnostics or rapid capture of myocardium which, in turn, result in pacing inhibition; 
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rapid ventricular pacing; or power-on resets that have the potential to cause tachy-
arrhythmias, hemodynamic compromise, inappropriate therapies, and battery drain.  
Iowa Model 
The evidence-based practice model used to integrate the practice change of 
performing MRI scans on CIED patients with a safety protocol was the Iowa model. The 
model served as a framework for applying evidence to practice with a systematic, 
iterative approach. The steps of the Iowa model include triggers to identify a clinical 
problem; determination of organizational priority; team formation; critique and synthesis 
of literature; piloting change; adopting practice; and ongoing analysis and evaluation of 
structure, process, and outcomes (Titler et al., 2001).  
Applying the current evidence based practice (EBP) project of a MRI safety 
protocol for scanning patients with CIED was as follows. The trigger was the identified 
need in which providers were unable to obtain the diagnostic information needed via 
MRI due to absolute contraindication based on CIED and the recent FDA approval of 
MR conditional devices. The need for safe MRI of CIED was identified by both the 
cardiology and radiology departments as an organizational priority. An appropriate team 
for the MRI protocol was comprised of a representative from electrophysiology, 
radiology, MRI technicians, advanced practice provider responsible for monitoring the 
test, scheduling, billing, and informatics specialists. Once the protocol was established, a 
piloting program with iterative feedback was initiated and monitored. Figure 1 depicts the 





Figure 1. MRI for pacemaker patients using the Iowa model. 
Adapted from “The Iowa Model of Evidence-Based Practice to Promote Quality Care,” 
by M. Titler, C. Kleiber, V. Steelman, B. Rakel, G. Budreau, and L. Everett, 2001, 
Critical Care Nursing Clinics of North America, 13(4), p. 500.  
Donabedian Framework 
The evaluation and analysis process of the Iowa model is supported by the 
Donabedian framework for quality, which examines structure, process, and outcomes 
(Donabedian, 1978). Interactions among providers and patients make up process. 
Structure refers to the environment, equipment, and resources with which the providers 
work. The actual change in the current and future health for a patient/population based on 




When the Donabedian framework was applied to the project, structure was 
comprised of the trained personnel performing and monitoring the test, appropriate MRI 
equipment, device interrogation equipment, and emergency equipment. The consistent 
application of the protocol, scheduling, prescreening, documentation, and billing 
comprised the process. Evidence that demonstrated safe and acceptable pre and post scan 
device settings and function and presence or absence of adverse patient outcomes were 
data supporting safe outcomes and an increase in overall number of MRI scans 
demonstrated increased access. Figure 2 depicts the Donabedian framework applied to 
the program for MRI of pacemaker patients.  
 
Figure 2. Theory application Donabedian framework. 
Adapted from “The Quality of Medical Care,” A. Donabedian, 1978, American 
Association for the Advancement of Science, 200(4344), 856-864. 
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Relevance to Nursing Practice 
The implication for advanced nursing practice was the advancement of the scope 
of practice for nurse practitioners at the organization and evaluated the safety and 
efficacy of the program in providing the CIED aggregate population with access to MRI 
as a diagnostic modality. Allowing advanced practice nurses to expand their practice to 
encompass new programs provides the opportunity to practice to the fullest extent of 
education and licensure and contribute as full members of the health care team as 
recommended by the IOM (2010). Expanding the role of the nurse practitioner for the 
application of an evidence-based protocol designed to improve safe patient access to 
diagnostic testing provided an opportunity for nurse practitioners to transform an area of 
health care delivery by decreasing a disparity in access and increasing medical product 
safety through appropriate monitoring. The essentials of doctoral practice and 
competencies for acute care nurse practitioners include the integration scientific evidence 
to develop and evaluate new practices using a theoretical approach. Furthermore, I 
examined the use of technology to improve patient care in an aggregate population, safety 
and quality with a systems approach for leadership and management in health care 
systems, and collaborative multidisciplinary teamwork (AACN, 2006, 2012). 
The translation and integration of evidence into clinical practice was integral to 
improving access to a diagnostic technology, MRI, for a growing aggregate population of 
aging patients with implanted CIED. As this aggregate population continues to expand 
with increasing comorbid conditions, the need for MRI as a diagnostic modality will 
become more prevalent. Denial of access to MRI may result in delayed or missed 
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diagnosis, which may have a myriad of implications for outcomes. This social change 
will serve as a bridge to the health care access disparity that exists for patients with 
implanted devices that are currently denied access to MRI diagnostic modalities. 
Professional organizations and clinical trials support the decision of the organizational 
leadership to change the practice paradigm. Ongoing evaluation was needed to 
demonstrate safe implementation of the new practice.  
Guidelines and Protocols 
The American Heart Association (AHA) published guidelines for MRI safety in 
CIED in 2007 (Levine et al., 2007). The AHA indicated that the presence of a pacemaker 
is a strong relative contraindication for MRI scanning and recommended doing so only if 
there is a significant clinical indication with additional cautionary statements for 
pacemaker dependent patients and those with internal cardiac defibrillators (ICD; as cited 
in Levine et al., 2007). The recommendations include informed consent, presence of an 
advanced cardiac life support (ACLS) and pacemaker experienced physician, 
consultation with radiology for lowest possible magnetic gradient, pre and post MRI 
device interrogations, continuous patient monitoring throughout the exam, and 
emergency equipment availability throughout the exam. Most of the study protocols 
found in clinical trials have been developed around the AHA recommendations with 
some variations in the monitoring staff and device interrogation techniques. Researchers 
have determined the effect of MRI on CIED and a safe method for proceeding with MRI 
scanning in those with CIED. The AHA has not yet updated guidelines for MRI of 
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pacemakers since the U.S. Food and Drug Administration (FDA) approval of MR 
conditional devices in 2011.  
On February 8, 2011, the FDA (2011) conditionally approved the first pacemaker 
that was considered safe under specific conditions. The FDA also required a post market 
study in which chronic lead performance and device function are followed for a 
minimum of 5 years (Mitka, 2011).  
The American College of Radiology (ACR, 2013) recommended following the 
manufacturer’s guidelines for the MR conditional device in place as there are differences 
in the device programming based on brand. The ACR recommended that all implanted 
hardware be verified through prescreening verification with the manufacturer of the 
device. Additional guideline recommendations that are applied to both MR conditional 
and non-MR conditional devices included signed informed consent, prescreening for 
device and leads including abandoned leads, consultation with cardiology, pre and post 
device interrogation, availability of emergency equipment, and 1-3 month follow up.  
Clinical Trials 
Prospective observational clinical trials have supported safe MRI of patients with 
CIED when selected and monitored with a safety protocol. Beinart and Nazarian (2012) 
conducted a large (n= 438) prospective study in which they developed a protocol for 
selection process and pacemaker testing with reprogramming pre and post MRI and 
continuous monitoring throughout the scan. There were statistically significant but 
clinically minor changes in devices. There were no long-term affects to the pacemaker 
function. Beinart and Nazarian concluded that protocol-based MRI in patients with 
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pacemakers was safe under conditions. Similarly, Boilson et al. (2012), in a smaller 
prospective study (n=32), identified “power-on” resetting of pacemaker devices in five 
patients with no adverse events noted. Hence, Boilson et al. endorsed the need for close 
patient monitoring and device assessment with scanning to maintain safety. Naehle et al. 
(2011) conducted a prospective trial (n=32) of patients with pacemakers undergoing 
cardiac MRI and found the risk/benefit ratio acceptable on those with right-sided devices 
but unfavorable on left-sided devices due to the artifact generated limited diagnostic 
imaging quality. 
The largest ongoing clinical trial examining MRI and pacemaker safety is the 
Magna Safe Registry. This is a prospective multicenter study in which patients with 
pacemakers or ICDs implanted after 2001 undergo nonthoracic MRI exam as clinically 
warranted using a protocol (Russo, 2013). Preliminary study results were presented at the 
American College of Cardiology (ACC, 2014) and revealed that of the 1,500 cases 
enrolled, only one ICD patient experienced device failure requiring urgent replacement, 
and this was found to be due to inappropriate programming of the device prior to exam. 
There were six incidences of atrial fibrillation/flutter and no ventricular arrhythmias 
documented. The findings of this study will change practice guidelines and 
reimbursement practices from the Centers for Medicare and Medicaid Services (CMS).  
Advances in technology have resulted in FDA approval of MRI conditional 
CIED. In 2011, the FDA approved the first MRI conditional device for use (U.S. Food 
and Drug Administration, 2011). The term MRI conditional is defined as “devices 
deemed safe under pre-specified MRI conditions” (Kodali, Baher, & Shah, 2013, p. 137). 
19 
 
These devices include features such as reduced ferromagnetic content, replacement of 
reed switch technology, modification of lead tips to reduce heating, shielding of circuitry 
to prevent electrical interference, and MRI programming modes (Cronin & Wilkhoff, 
2012). Random controlled trials have been conducted to assess the safety of MRI 
conditional devices.  
Gimbel et al. (2013) conducted a randomized controlled trial in which 236 
patients were randomized in a 2:1 ratio for MRI scanning after placement of an MR 
conditional pacemaker system and found no MRI related complications and no 
significant differences in pacemaker capture thresholds between groups. Wilkhoff et al. 
(2011) also found in a randomized controlled trial (n=464) no MRI related complications 
during or after MRI scans in patients with MRI conditional devices and concluded that 
the specialty dual chamber pacemaker could be exposed to MRI at 1.5T without adverse 
patient outcomes or pacemaker system function. Shenthar et al. (2015) conducted a 
randomized control trial in which 266 patients were randomized at a 2:1 ratio for MRI 
scanning 9-12 weeks after implantation of the MRI conditional Medtronic Novus 5076 
lead. Shenthar et al. concluded that MRI can be safely performed without restriction to 
position when these pacemaker leads were connected to an MRI conditional device. In a 
study examining the effect of MRI on MRI conditional ICDs, Gold et al. (2015) found no 
MRI complications, no differences in pacing and sensing amplitudes, and no impact on 
detections and therapy delivery between groups.  
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Local Background and Context 
In 2011, the FDA approved the first pacemaker that is conditionally MR safe 
under specific conditions (FDA, 2011). However, few organizations offer MRI of 
pacemaker patients despite the new technology. The project site maintained the policy 
that the presence of a pacemaker was an absolute contraindication to MRI. This policy 
included a hard stop in the electronic medical record for ordering the exam if a 
pacemaker was present (See Appendix B). There was an increase in electrophysiology 
consults requesting assistance with diagnostic imaging recommendations for patients 
with CIED; and therefore, a multidisciplinary team was formulated to develop a policy to 
address the issue.  
The project site was a 732-bed level 1 trauma medical center that serves as the 
state’s referral resource for advanced tertiary and quaternary care. Therefore, it was 
necessary to provide current diagnostic options in order to provide the best possible 
quality care to patients. This change in the practice paradigm had the potential to impact 
an aggregate population of residents throughout the entire state.  
Definition of Terms 
 The following are operational definitions used for this project:  
1. Abandoned leads. Pacemaker leads that were retained in the body but no 
longer attached to a generator.  
2. Device function. Lead impedance and pacing thresholds were used to define 
device function. Appropriate device function was determined by lead 
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impedance between 200-1500 ohms (Ω) and a pacing threshold of <2.0 V at 
0.4 ms with < 0.5 V change upon repeat testing.  
3. MR conditional. Items were considered safe in the MRI environment when 
specific conditions of use were met (ACR, 2013).  For the purpose of this 
project a MR conditional pacemaker was an entire system that included 
generator, leads, and all connecting devices that met the MR conditional 
requirements. The presence of any leads, extenders, or connectors that were 
not MR conditional rendered the entire system not MR conditional. 
4. Pacemaker. The term pacemaker encompassed the implanted generator and 
lead system which produces low voltage electrical impulses to manage cardiac 
conduction disorders. This included devices with or without defibrillator 
capabilities (Kenny, 2008).    
Role of the DNP Student 
As an acute care nurse practitioner in the adult cardiovascular internal medicine 
hospitalist program, I have encountered patients with CIED and co-morbid conditions 
requiring MRI as a diagnostic modality which increased the complexity of management. 
These cases prompted a review of the literature regarding MRI in pacemaker patients, 
and consultation with the Electrophysiology (EP) service. The EP service nurse 
practitioner revealed that, based on the recommendations of the electrophysiology and 
radiology physicians, there were plans to develop an organizational policy for this 
aggregate population. The EP nurse practitioner agreed to serve as my preceptor for 
doctor of nursing practice (DNP) studies. Practicum experiences included learning 
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pacemaker technology/function, participating in the development of a policy/workflow 
for MRI of pacemaker patients, and educating ordering providers. This project was 
approved by the healthcare organization for piloting. For my capstone project, I collected 
data from the records of the patients undergoing MRI of MR conditional devices, and 
evaluated the data for consistent application of the protocol, device function outcomes, 
and patient-reported symptoms.    
Summary 
The FDA approved MR conditional pacemaker technology in 2011 (FDA, 2011). 
This advance in technology has been supported with clinical trials and professional 
organization guidelines. Until recently, the organizational site continued to deny 
pacemaker patients access to MRI based on a policy in which the presence of a 
pacemaker was an absolute contraindication to MRI. However, a change in practice was 
initiated and the policy was changed to include MRI scanning of MR conditional cardiac 
devices with the use of an evidence-based practice protocol. This protocol was piloted 
and evaluated to ensure consistent and safe implementation through the collection of 
evidence regarding program fidelity and CIED function. A documentation template was 
developed in order to collect data which were analyzed using both descriptive and 





Section 3: Collection and Analysis of Evidence 
Introduction  
There is an increasing cohort of individuals with CIEDs who are denied access to 
the diagnostic modality of MRI. New technology, supported with evidence from clinical 
trials and professional organization guidelines, has led to a change in the practice 
paradigm resulting in the implementation of an evidence-based practice protocol pilot for 
MRI of MR conditional devices. This quality improvement project was designed to 
evaluate the pilot and answer the following question: Does the implementation of a nurse 
practitioner managed practice protocol result in consistently safe access to MRI as a 
diagnostic tool for patients with MR conditional pacemakers? In this section, I review the 
methods, data collection, and evaluation intended to provide evidence regarding the 
safety of the newly implemented protocol. 
Practice Focused Question 
Until the implementation of the pilot program, organizational practice treated the 
presence of a pacemaker as an absolute contraindication to MRI scanning, and no patient 
with a CIED had access to the diagnostic modality of MRI (see Appendix B). Adoption 
of an evidence-based protocol in which nurse practitioners with expertise in pacemaker 
programming managed monitors this patient population during MRI scanning has the 
potential to increase safe patient access to a diagnostic modality. The purpose of this 
project was to evaluate a pilot protocol to determine patient demographics, program 
fidelity, and appropriate device function. 
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Sources of Evidence 
The health facility adopted a new clinical practice to allow adult patients with an 
MR conditional pacemaker, a clinical indication, and a provider order for MRI to be 
allowed access to an MRI. Prior to MRI, the patients were screened by the nurse 
practitioner for inclusion/exclusion criteria for MRI scanning based on the evidence-
based established criteria and the manufacturer recommendations for the device 
implanted in the patient. Inclusion criteria included patients over the age of 18 with 
permanent MR conditional pacemaker device and lead systems implanted for greater 
than 6 weeks with a clinical indication for MRI diagnostic evaluation and no additional 
contraindication to MRI scanning or the presence of exclusion criteria. Exclusion criteria 
included those less than 18 years of age, less than 6 weeks since CIED implantation, all 
components of the pacemaker system were not FDA approved as MR conditional, fever, 
or the presence of additional contraindications to MRI. Those with abandoned leads were 
also excluded regardless of MR conditional status. Additional contraindications were 
based on the manufacturer recommendations for the implanted device 
Data were obtained via the medical records of these MRI patients. A record of the 
procedure was included in the electronic medical record using a template. These data 
were evaluated for adherence to protocol and pre and post device function. The 
cumulative clinical indicator data were used in a summative manner to evaluate overall 
safety and efficacy of the protocol. Data collected included gender, age, device 
manufacturer, MRI body site, pre and post MRI device thresholds, pre and post MRI lead 
impedance, and patient reported device-associated symptoms during the MRI.  
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A template was created to document within the patient record appropriate 
screening, device function, monitoring, and scanning. The use of documentation 
templates captured the necessary data elements (see Appendix C). This standardized 
documentation was completed by the provider responsible for device programming and 
patient monitoring during the MRI scan. This served as the procedural note in the patient 
record and supported billing to ensure that the organization could optimize 
reimbursement for the care delivered. Use of one documentation template to serve 
multiple purposes decreased the likelihood of missing elements. 
Protection of Human Subjects  
In 2003, the Hastings Center convened experts to address ethical issues associated 
with quality improvement (QI) methods in the United States. The group defined QI and 
the ethical requirements for QI activities. QI was defined as “systematic, data-guided 
activities designed to bring about immediate improvements in health care delivery in 
particular settings” (Lynn et al., 2007, p. 667). QI is focused on actions designed to 
improve care supported by data as a reflection of effect and is considered both necessary 
and normal for health care operations. Improving quality of care is considered an ethical 
responsibility of health care providers. As such, consent to receive care often implies 
participation in QI unless such participation would subject the individual to additional 
surveys and/or medical procedures. Lynn et al. (2007) provided the examples of 
introduction of procedures to reduce medical errors or adoption of new guidelines as QI 
activities. The program for MRI of pacemakers fell into this category as the procedure is 
not experimental, was approved by the FDA in 2011, and was recognized by CMS as a 
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reimbursable procedure. The design of this program was to ensure that recommended 
guidelines were followed in a consistent manner for quality and safety.    
The organizational internal review board granted a waiver stating that this project 
does not meet the regulatory definition of human subject research as it is a QI project 
involving the evaluation of expanded practice guidelines approved by the medical 
practice committee. 
Analysis and Synthesis 
Evaluation is an ongoing process designed to provide information regarding 
program implementation; effectiveness; efficiency; cost effectiveness; and attribution for 
the purpose of description, improvement, adaptation, and decision making. A formative 
evaluation was performed to determine if the program goals were attained (Hodges & 
Videto, 2011). A formative evaluation involves using data to develop or improve a 
program (Hodges & Videto, 2011). The data in a formative evaluation are used to test 
“plans, messages, materials, procedures, and modifications to existing programs” 
(Hodges & Videto, 2011, p. 207). This evaluation is used to examine pilot testing for 
unexpected problems or outcomes. The evaluation was comprised of indicators of 
adherence to manufacturer recommendations, stable device function, and patient-reported 
symptoms. If the evaluation demonstrated that these indicators support the safety and 
efficacy of MRI scanning for this aggregate population, then the nurse-practitioner-led 
program will be formally adopted as a practice change as outlined in the Iowa model for 




A summary of the sample for this project was provided through descriptive 
statistics (Terry, 2015). A distribution of the age, gender, device manufacturer, and body 
area scanned were used to describe the sample population undergoing MRI. This 
descriptive data provided a demographic illustration of the patients in this program. The 
demographic data were analyzed and reported using descriptive statistics and reported 
means and frequency distribution. 
Program Fidelity 
The guidelines for MRI of MR conditional devices recommend adherence to 
manufacturer specifications for scanning. The device specifications, while often similar, 
do have variation. Therefore, assessment of the screening criteria allowing evaluation of 
use of appropriate prescreening criteria is an outcome to demonstrate appropriate 
application of the program by the nurse practitioner. The criteria for each device 
manufacturer were embedded in the documentation template, and the provider selected 
the criteria based on the device. All criteria had to be met in order to be considered 
appropriately screened. The screening criteria were collected as nominal data with a 
yes/no response. Frequency distribution demonstrated how often the screening criteria 
were completely met.   
Clinical Indicators 
Planas (2008) reported that clinical indicators are considered the main source for 
measuring effectiveness. Clinical indicators to assess the successful implementation of a 
protocol for MRI on MR conditional pacemaker patients included device function 
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pre/post MRI scan and patient reported symptoms during MRI scan. This clinical 
indicator measurement was achieved through device interrogation completed by a nurse 
practitioner with measurement of thresholds and lead impedance for each implanted lead 
before and after MRI scanning. The clinical indicators of device function were collected 
and evaluated in an ongoing manner with data for each patient collected and analyzed. 
This information was located within the body of the documentation template. 
Lead impedance is the amount of resistance to the flow of electrical current from 
the cardiac-implanted electrical device through the lead, and it is a predictor for device 
longevity and function (Kenny, 2008) Acceptable impedance range is 200-1500 ohms 
(Ω). Low lead impedance could indicate a defect in the insulation of the lead while high 
lead impedance is often associated with lead damage, lead fracture, or loose setscrew 
(Hayes, Asirvatham, & Friedman, 2013). Due to the range for lead impedance for 
acceptable device function, these data were collected as nominal data in which yes 
indicates lead impedance within acceptable range and no indicates lead impedance 
outside of the acceptable range. Further assessment was performed by using a paired t-
test to determine if there was a statistically significant change in means between pre and 
post MRI exposure. These data were measured in ohms.  
Kenny (2008) defined pacing thresholds as “the minimum amount of energy 
required to reliably capture (cause depolarization of) the heart” (p. 161). Determining the 
pacing threshold allows for programming with a safety margin to ensure capture and 
appropriate pacing. Increased thresholds will decrease the longevity of the device through 
battery depletion as a result of increased electrical output. Pacing thresholds are not 
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static, and there will be ongoing variability; hence, an increase of greater than 0.5 V @ 
0.4 ms is the established parameter of a threshold change requiring further evaluation. 
Medication, electrolyte imbalance, new myocardial infarction/tissue damage, and lead 
dislodgement are the most likely causes of variation in pacing thresholds (Hayes et al., 
2013). A paired t-test was used to make inferences regarding pre and post threshold 
measurements.  
Professional guidelines and manufacturer recommendations for MRI and MR 
conditional devices include ongoing verbal communication with the patient to assess for 
any symptoms experienced during the MRI scan. These data were collected in the format 
of yes/no answer for patient reported symptoms. The documentation template included 
free text for a description of symptoms in the event that these data would require further 
analysis. These data were collected as nominal data and reported with a frequency count. 
A McNemar chi square test was performed to compare the presence of symptoms pre and 
post MRI.  
Summary 
This new nurse practitioner, evidence-based protocol was applied to patients with 
MR conditional pacemakers. As a QI project based on an existing protocol, this project 
was exempt as human subjects research.  
Descriptive statistics, program fidelity, and clinical indicators were examined as 
part of a formative evaluation. Data collected included device type, MRI site, adherence 
to manufacturer recommendations, pre/post device interrogation parameters, and patient-
reported symptoms. The documentation template for MRI of pacemaker patients 
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contained the descriptive data, documentation of adherence to manufacturer guidelines, 
pre/post device interrogation findings, and any symptoms reported by the patient. The 
collected data were analyzed with descriptive and inferential statistics in order to make a 
determination regarding the safety of the pilot protocol.  
The following is a discussion of the findings and implications based on the data 




Section 4: Findings and Recommendations 
Introduction 
There is an increasing cohort of individuals with CIEDs who are currently denied 
access to the diagnostic modality of MRI. New technology, supported with evidence from 
clinical trials and professional organization guidelines, has led to a change in the practice 
paradigm resulting in the implementation of an evidence-based practice protocol pilot for 
MRI of MR conditional devices. This QI project was designed to evaluate the pilot and 
answer the following question: Does the implementation of a nurse practitioner managed 
practice protocol result in consistently safe access to MRI as a diagnostic tool for patients 
with MR conditional pacemakers? This section provides a discussion of the data analysis 
findings and implications, recommendations, and strengths and limitations. Data 
collection included age, gender, device manufacturer, MRI site, use of manufacturer 
checklist, pre and post MRI lead impedance and pacing thresholds, and patient-reported 
symptoms. The data were collected via chart review and analyzed using SPSS software.  
Findings and Implications 
Data were collected for MRI performed on MR conditional CIED via the 
electronic medical record. The data were de-identified and compiled in an Excel 
spreadsheet and analyzed using SPSS software. An analysis of the data included 
descriptive data regarding age, gender, device manufacturer, MRI site, and use of 
manufacturer checklist. Categorical data were reported in frequencies and percentages, 
and continuous data were reported in means. Inferential statistical analysis including 
paired t-tests, and McNemar chi square was used to analyze the clinical outcome data 
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including pre and post MRI lead impedance, pacing thresholds, and patient-reported 
symptoms. 
Descriptive Data 
A total of 34 MRI scans were performed on 29 patients with MR conditional 
pacemakers between June 2016 and April 2017. Five of the MRI scans performed were 
repeat scans on patients requiring MRI surveillance of a condition or MRI for another 
indication. Repeat MRI scans were not addressed in the original policy, and there was 
concern that repeated exposure to radiofrequency fields could have a cumulative effect on 
device function. Russo et al. (2012) used Magna Safe Registry data in which 12% (n=43) 
of the patients had undergone more than one MRI and up to as many as seven and 
determined that there was no association between the number of MRI scans and adverse 
effects to the patient or device. Later analysis of the same registry was published with 
report of as many as 11 MRI scans in one patient (Russo et al., 2017). The median 
interval between repeated scans was 153 days (Russo et al., 2017). There were no 
clinically significant differences in patients who underwent repeated scanning versus 
those who had a single MRI scan; however, there were changes to the shock lead 
impedances in patients with ICDs (Russo et al., 2017). These changes required no 
intervention (Russo et al., 2017). The devices in the Magna Safe study were not MR 
conditional, whereas those in the pilot program were all labeled MR conditional.  
There were 20 (59%) male and 14 (41%) female patients with a mean age of 65.7 
years and a median age of 66 years. This age was younger than the average age 75.4 years 
at which pacemakers are implanted (Greenspon et al., 2012).  
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The group was comprised of patients with three MR conditional device 
manufacturers: Medtronic (47%), Biotronik (41%), and Boston Scientific (12%). The 
variation in the representation of manufacturers was likely due to the amount of time each 
brand has been available on the market leading to more devices implanted. This variation 
was likely due to the dates in which FDA approval was granted for the technology with 
Medtronic receiving initial approval in 2011, Biotronik in 2014, and Boston Scientific in 
2016 (Biotronik, 2014; Boston Scientific, 2016; FDA, 2011). This variation may also be a 
result of regional implanting provider preferences and purchasing contracts. Figure 3 
illustrates the device manufacturers represented in the program pilot.  
 
Figure 3. Device manufacturer. 
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In some cases, more than one body area was scanned per patient for a total of 38 
anatomical sites. The anatomical areas scanned included 52.6% brain, 28.9% spine, 7.9% 
abdomen/pelvis, 7.9% lower extremity, and 2.6% other. Brain and spine imaging 
comprised 81% of the sample. This was consistent with findings in studies of MRI and 
pacemakers with 75% of MRI scans in the Magna Safe registry and 89% in a single 
center trial targeting brain and spine as the anatomical site scanned (Russo et al., 2017; 
Strom et al., 2017). 
There were no MRI scans involving thoracic sites during the pilot program. 
Scholars have demonstrated that full body scanning is safe for appropriate pacemaker 
function (Gimbel et al., 2013; Naehle et al., 2011). However, Naehle et al. (2011) 
reported that image quality and diagnostic value may be decreased as a result of the 
ferromagnetic material interference in the views needed for cardiac MR and other 
structures in the thoracic region. Thoracic imaging was excluded from the Magna Safe 
Registry study (Russo et al., 2017). Horwood et al. (2017) conducted a study using CIED 
and MRI conditions that have been excluded in previously published studies and found 
that of 94 patients who underwent cardiac MRI, four of those studies were considered 
nondiagnostic due to extensive artifact related to device proximity.  
The largest number of MRI referrals were generated for neurological symptoms 
leading to MRI of the brain and/or spine. However, increased education and awareness 
regarding the pilot program may lead to an increase in referrals from other services for 





Figure 4. Anatomical site. 
Program Fidelity 
Program fidelity was evaluated by determining if manufacturer specifications 
were met during the prescreening evaluation of the patient. In 94% of all cases, the 
manufacturer recommendations were met. In the two cases that did not meet prescreening 
requirements, the ventricular lead threshold exceeded 2.0 V @ 0.4 ms. Each of these 
cases were reviewed by the electrophysiology team. and it was determined that the 
pacemaker settings did not require the lead in question in order to function properly and 
the patient was not pacemaker dependent. There was no change in device lead function 
post scan. 
Clinical Indicators 
Clinical indicators for this project were measures of CIED function based on 
measurement of pacemaker lead impedance and lead thresholds obtained through device 
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interrogation for each implanted lead before and after MRI scanning. Langman, 
Goldberg, Finn, and Ennis (2011) reported that lead tip heating due to radiofrequency 
fields generated by MRI is dependent on lead length and termination condition (i.e., 
attached or unattached). Therefore, changes in lead impedance and pacing thresholds pre 
and post MRI were examined separately for atrial and ventricular leads as ventricular 
leads are longer than atrial leads. Additionally, not all pacemaker systems are comprised 
of an atrial lead.  
Lead impedance. Lead impedance is not static, and there will be ongoing 
variability; hence, there are established acceptable parameters for evaluation. 
Recommended lead impedance range is 200-1500 ohms (Ω) (Hayes et al., 2013). An 
increase of 50 Ω should generate further investigation of device function (Russo et al., 
2017). During the pilot, no lead impedance measurements pre or post MRI scan were 
outside of the acceptable range.  
The change in lead impedance was further examined with a paired t-test. This 
parametric test is designed to examine the difference in two paired means at two different 
times such as pre and post MRI (Polit, 2010). As shown in Table 1, the t-test revealed that 
the pre MRI atrial lead impedance mean (M= 524.8) was not significantly different post 
MRI (M = 516), t (22) = 1.09, p = 0.29. The t-test revealed that the pre MRI ventricular 
lead impedance mean (M= 556.2) was not significantly different from post MRI (M = 





Paired t-test Results for Lead Impedance 

















- 1.39 26 0.17 
 
Pacing thresholds. Pacing thresholds are not static, and there will be ongoing 
variability in measurement (Hayes et al., 2013). The acceptable change in pacing 
threshold for each lead is 0.5 V @ 0.4 ms. In the pilot program, there were no changes 
outside of the acceptable recommendation for pacing thresholds.  
The change in pacing thresholds were further examined with a paired t-test. This 
parametric test is designed to examine the difference in two paired means at two different 
times such as pre and post MRI (Polit, 2010). As shown in Table 2, the t-test revealed that 
the pre MRI atrial lead pacing threshold mean (M = 0.8) was not significantly different 
post MRI (M = 0.78), t (22) = 0.64, p = 0.52. The t-test revealed that the pre MRI 
ventricular lead pacing threshold mean (M = 0.94) was not significantly different from 






Paired t-test Results for Pacing Thresholds 





t df p 
Atrial 
Threshold 
0.8 (0.28) 0.78 (0.23) 0.64 22 0.53 
Ventricular 
Threshold 
0.94 (0.42) 0.86 (0.33) 1.66 27 0.11 
 
Therefore, the null hypothesis was confirmed that there was no significant change 
in MR conditional pacemaker function based on the clinical indicators of lead impedance 
and pacing thresholds associated with MRI exposure.  
Patient-Reported Symptoms 
 The occurrence of pacemaker-associated symptoms, such as dizziness, 
presyncope, palpitations, or warmth/vibration at the pacemaker site were documented 
within the patient record, and during data collection, they were recorded as symptomatic 
or asymptomatic. One patient was experiencing intermittent symptoms related to 
pacemaker settings upon arrival for MRI, and two patients reported symptoms during the 
MRI. A McNemar chi square was performed to assess the pre and post MRI incidence of 
patient-reported, pacemaker-associated symptoms, and there was no statistically 
significant difference in the presence of symptoms pre and post MRI, p = 1.00. This result 
should be interpreted conservatively as the recommended minimum frequency of cases in 
all crosstabulation cells is 5, and this condition was not met (Polit, 2010). Therefore, the 
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null hypothesis that patients will have no increased pacemaker associated symptoms with 
MRI exposure is tentatively confirmed.  
Implications 
 Based on the preliminary findings during the pilot program for MRI scanning of 
patients with MR conditional CIED, the program has been consistently and safely applied 
to the aggregate population with no detrimental effects to CIED function. These finding 
will support the recommendation of adoption of the policy and program for MRI of MR 
conditional pacemakers within the organization. The overarching implication of this 
program will be access for a diagnostic modality, MRI, to an aggregate population of 
patients who have previously been denied this option. Over the course of 10 months, 34 
scans were performed at the organization. This is significant when considering that 
despite the introduction of MR conditional CIED in 2011, many organizations continue to 
deny MRI as a diagnostic modality for these patients. Sabzervari et al. (2017) surveyed 
hospitals in England regarding MRI services offered to patients with CIED and found that 
although 98% of respondents were aware of the new technology, only 46% offered MRI 
to patients with MR conditional devices, and only three of those centers performed 
greater than 20 scans per year.  
Recommendations 
 Adoption of the policy and pilot program as practice within the organization is 
recommended. Based on observations during the pilot program and scholars demonstrating 
new and evolving evidence, recommendations for changes to the program can be identified. 
The Iowa model used in the development of the pilot program requires iterative feedback 
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and evaluation (Titler et al, 2001). Therefore, recommendations regarding changes to the 
current program, increasing the scope of the project, and areas of future study have been 
identified for discussion.  
Current Program 
The original protocol was designed for scheduled, prescreened patients. As this 
project has developed and providers have learned that it is now possible to safely obtain 
MRI on some pacemaker patients, there have been requests for MRI in scenarios not 
addressed in the protocol, such as urgent and emergent MRI. Over the course of the pilot 
program, six (17.6%) urgent or emergent MRI scans were performed. All of these MRI 
scans were completed during normal business hours; therefore, this may not represent 
after hours requests when the trained personnel were not present to address the request. 
There was no mechanism in data collection to track denied emergent requests. Strom et 
al. (2017) reported performing 22.7% of MRI exams as emergent or urgent in their single 
center study. 
The requests for emergent and urgent MRI scans were all based on neurological 
symptoms. Chalela et al. (2007) found that MRI was able to detect acute ischemic stroke 
more often than CT. MRI detected acute ischemic stroke 46% (CI 35-56%) in 
comparison to CT which detected only 10% (CI 7-14%) of acute ischemic strokes 
(Chalela et al., 2007). The ability to detect acute ischemic stroke went up for MRI in 
those patients scanned within 3 hours of symptom onset with MRI detecting 46% and CT 
7% (Chalela et al., 2007). Despite the importance of rapid diagnosis and treatment for 
stroke symptoms, Nazarian et al. (2016) found that among patients with neurological 
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stroke symptoms, 44% of patients without CIED were likely to have MRI imaging versus 
1% of patients with ICD implants.  
The request for emergent MRI services on patients with MR conditional 
pacemakers has implications for staffing, finance, and scheduling. Although there seems 
to be no reason that the protocol could not be applied on an emergent basis contingent 
upon appropriate screening, if emergent/urgent MRI is to be offered to this aggregate 
population, it would require a larger staff training effort with on-call responsibilities, 
scheduling, and wages. Further analysis of return on investment from a clinical impact 
and financial perspective would be needed. In discussion of emergent and urgent MRI of 
CIED, Gimbel (2017) opined, “a well-honed care pathway for such patients needs to be 
developed and maintained; a scattershot approach to care is likely a recipe for confusion 
and misadventure” (para. 5). 
Increasing Scope 
 The pilot program for this project addressed MRI of MR conditional CIED. While 
there was literature supporting the safety of MRI in patients with non-MR conditional 
technology, referred to as legacy devices, prior to beginning the pilot program, a 
landmark study was published during the project. Russo et al. (2017) reported the 
findings of the Magna Safe Registry in which 1000 patients with legacy pacemakers and 
500 patients with legacy ICDs underwent clinically indicated, non-thoracic MRI scans 
after appropriate screening, device reprogramming, and monitoring protocol. There was 
one power on reset requiring device replacement, six episodes of arrhythmia, and six 
partial electrical resets (Russo et al., 2017). Device setting changes occurred; however, 
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did not meet criteria for clinical significance (Russo et al., 2017). Hence, increasing the 
evidence that legacy devices can be safely scanned with use of an evidence-based 
protocol. A Canadian Consensus Statement places the incidence of serious adverse or 
life-threatening events from MRI of legacy devices at <1% (Verma et al., 2014).  
 Expanding the scope of the pilot program to include legacy devices would 
increase access to MRI as a diagnostic modality. However, the Centers for Medicare and 
Medicaid Services (CMS) do not provide reimbursement for this procedure which 
remains an off-label use according to the FDA (Kramer & Kesselheim, 2017). According 
to Kramer and Kesselheim (2017), this reimbursement decision was amended by CMS to 
allow coverage for those with legacy devices that undergo MRI through participation in a 
prospective registry. Private insurers generally reflect CMS practices. Therefore, patients 
with legacy devices must undergo MRI at registry centers in order to insurance to provide 
reimbursement. The staffing and monitoring burden for the maintenance of a registry 
makes expansion of the scope of the program a significant clinical and administrative 
decision to be addressed over time.   
Strengths and limitations of the project 
 This project was limited by the small number of scans performed. The sample 
group was a convenience sample comprised of all patients with MR conditional CIED 
referred to the single academic medical center for MRI. Thus, this cohort had the 
potential to have referral bias. There was no control group for comparison as this was a 






 Throughout the course of the pilot program for MRI of MR conditional pacemaker 
patients, additional questions arose regarding this procedure and aggregate population. A 
literature review identified gaps in knowledge such as determination of exam utility and 
outcomes, device implant decisions, patient experience and perceptions, and special 
circumstances such as the use of general anesthesia and sedation. These identified gaps in 
knowledge are discussed for future study.  
Exam Utility 
As MRI of CIED increases in practice, there remains risks attendant to the procedure 
and the supervisory burden for the exam. A mechanism to monitor the utility of MRI exam 
should be considered. Strom et al. (2017) developed criteria for determination of utility of 
MRI studies. The criteria included interpretable study, identification of new diagnosis, 
confirmation of diagnosis, and/or change in treatment plan based on MRI results (Strom et 
al., 2017). If the MRI exam was interpretable and one other criterion was met, the MRI was 
judged useful (Strom et al., 2017). However, this does not translate to a demonstrable 
change in long term outcomes and more study is needed to address this gap in knowledge.  
Determinants of Type of Device Implanted 
 As more evidence is published regarding the safety of MRI of legacy pacemakers 
there is increasing discussion regarding clinician selection of which type of device to 
implant going forward. The new MR conditional technology is more expensive, 
approximately $500 per system; however, even though considered safe the risk of off 
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label scanning in non-conditional devices is not zero and it is not reimbursed by CMS 
(Gimbel, 2017). Gimbel (2017) reports there are no head to head comparisons of MR 
conditional versus non-MR conditional devices exist. More evidence is needed in order to 
guide patients to the appropriate device while considering safety, access, and expense.  
Patient Experiences and Perceptions 
Anecdotally, many patients with CIED who presented for MRI described anxiety 
and fear for the safety of the procedure and potential effects on device function. In a 
grounded study of pacemaker patients, Malm and Hallberg (2006) found themes of 
imposing restrictions which were based in lack of understanding regarding what was safe 
for the device in daily life scenarios. Electromagnetic fields were specifically mentioned 
as technology likely to pose a threat to the appropriate function of the pacemaker (Malm 
& Hallberg, 2006). Many subjects reported feelings of unease in proximity to such 
technologies (Malm & Hallberg, 2006). MR conditional devices are new technology with 
FDA approval occurring in 2011(FDA, 2011). Patients may have peers with older 
technology that are not able to have MRI and this could cause confusion and concern for 
the safety of the test.  
The MRI examination may be anxiety producing in many patients. Van Minde, 
Klaming, and Weda (2014) reported MRI associated anxiety due to claustrophobia, loud 
noises, table movement/vibration, and duration of the test. These scholars found the 
highest level of anxiety existed at the beginning of the exam (Van Minde et al., 2014).  
Therefore, education and reassurance regarding the safety precautions for MRI 
testing will be needed for informed consent and decreased anxiety. The development of 
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educational materials for this aggregate population would be ideal. There is no literature 
that addresses MRI and pacemaker anxiety and this identified gap in literature would 
require further study in order to understand and develop interventions for this 
phenomenon.  
Sedation and Anesthesia for MRI of Pacemaker Patients 
During the pilot study, there were two requests for MRI with general anesthesia or 
sedation. These requests were declined after review of literature and manufacturer 
guidelines. Guidelines for MRI of MR conditional devices require that manufacturer 
recommendations be followed (ACR, 2013). The guidelines state that monitoring staff 
must have visual and verbal contact with the patient for the entire exam and this is not 
possible in the setting of general anesthesia or any sedation other than light (Medtronic, 
2013). Manufacturer technical support services were contacted and the use of general 
anesthesia was reported as off label use. Review of the literature revealed no studies with 
evidence to support this practice and therefore a gap in knowledge has been identified for 
future study.  
Summary  
 The data was analyzed using SPSS software. Descriptive data was used to 
describe the population who were included in the pilot program. Program fidelity was 
reported as frequency data. A paired t-test was used to evaluate for differences in lead 
impedance and pacing threshold. This revealed no statistically significant changes 
between pre and post MRI. Patient-reported symptoms were examined using the 
McNemar chi square test. This test revealed no significant difference. These findings 
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were used to endorse the adoption of the pilot program as policy for the organization. 
Based on experiences in the pilot program, consideration of additional program policy for 
urgent/emergent MRI scanning and increasing scope to include legacy devices were 
recommended. Areas of future study were discovered throughout the course of the pilot 
and include exam utility, device selection, patient anxiety, and MRI in the setting of 
anesthesia and sedation.  
In the final section a dissemination plan and evaluation of learning throughout the 
course of the project will be discussed.  
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Section 5: Dissemination Plan 
Dissemination 
Ousley et al. (2010) reported that access to evidence is one of the early steps in 
translation of evidence to practice. Walsh (2010) found that respondents to a survey 
regarding use of evidence-based practice (EBP) indicated that the primary opportunity for 
EBP arose from the availability of evidence. Hence, it is important for clear and concise 
dissemination of results from research endeavors. Forsyth et al. (2010) discussed the 
increasing importance of dissemination of EBP initiatives in order to replicate and apply 
evidence to improve health care quality. Forsyth et al. opined that dissemination is where 
the true benefit of practice change initiatives takes place. As a scholar-practitioner and 
nurse leader, it is important to both disseminate findings and to be aware of dissemination 
of the findings of others in order to lead translation of evidence into practice. Ultimately, 
dissemination of evidence should support and promote innovation in practice for high 
quality care through the contributions of engaged providers. Inadequate dissemination 
and adoption of EBP creates a chasm between best practices and actual care.  
I have selected a poster presentation at my organization’s annual nursing quality 
symposium as the format and forum approach for dissemination of my project findings. 
See Appendix D for poster design. I chose a poster presentation for many of the reasons 
found outlined in Forsyth et al. (2010) including less formal, no time restrictions, and the 
ability to edit based on audience. Forsyth et al. reported the major benefit of poster 
presentations is “[p]rovision of a less stressful and inviting environment to disseminate 
EBP project information is essential to ensure active involvement of clinically-based 
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health care professionals” (p. 16). This promotes dissemination of evidence in a format 
that could be less intimidating than others, which may increase dissemination efforts. 
The information presented in a poster can be customized to the audience. The 
added benefit of the poster presentation was described by Hand (2010) in which the 
poster only serves to attract interest; with the average time spent reading a poster being 3-
5 minutes, it is then up to the presenter to demonstrate in-depth knowledge of the topic 
that can cater to the interests of the individual engaged. For example, the points I might 
choose to discuss with an EP nurse practitioner regarding MRI protocols for pacemaker 
patients would differ from the information I might share with a primary care provider 
who might be considering ordering this diagnostic modality for a patient in this aggregate 
population. 
Analysis of Self 
Over the course of my doctoral studies and project, I found a significant change in 
how I approached topics, such as leadership, advanced practice, QI, health outcomes, and 
health policy. The future benefits of my doctoral degree and career advancement are also 
included in the analysis of myself.  
Leadership 
 Improvement in leadership skills was one of the main goals I identified for the 
doctoral capstone project. Through the practicum experience and DNP project process, I 
have increased my understanding of organizational and systems issues that can impact 
health care.  
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 There are many types of intelligence that comprise effective leadership. These 
include emotional, social, and political. Emotional intelligence involves self-awareness 
and self-management to manage interactions with others (Jones, 2016). Political 
intelligence requires astuteness in adjusting to situational needs in a way that can 
influence others (Jones, 2016). Social intelligence demonstrates the ability to create 
positive feelings in those whose support is needed (Jones, 2016). The opportunities 
afforded by the doctoral project experience have allowed me to develop in all three 
intelligence arenas.  
Throughout the course of my project, I found it necessary to work collaboratively 
with an array of interdisciplinary professionals, such as radiology, internal medicine, 
information technology, administration, billing, and scheduling. Additionally, the nursing 
department and internal medicine department shared oversight of my project activities as 
a DNP student. I gained political intelligence as I worked with these departments to meet 
organizational requirements to plan and implement a change in the practice paradigm. I 
feel that I have developed leadership skills that will prove useful moving forward in a 
leadership role as scholar-practitioner. 
I believe I am prepared to be a leader in health care issues. My doctoral project 
experience has taught me to look to the literature to understand problems, discuss topics 
with other team members to understand their perspective, and engage in a meaningful 
way to become a change agent. The DNP experience has allowed me to broaden my 
knowledge base and approach complex issues with an understanding of the system as a 
whole. When I first began the doctoral project, my approach to leadership focused much 
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more on the immediate circumstances and needs. I was more managerial in my approach 
with attention to organization and established policy. Now, as a leader, I am able to 
discuss ideas, impact, and engagement associated with practice change. 
Advanced Nursing Practice 
 There are eight core competencies that are considered essential for advanced 
practice nursing at the doctoral (DNP) level. These include scientific underpinnings, 
organizational and systems leadership, clinical scholarship and EBP, information systems 
and technology, policy and advocacy, interprofessional collaboration, population health, 
and advanced practice nursing (AACN, 2006). My initial impression of the DNP essential 
competencies was that not all were necessarily applicable to my career goals as an acute 
care nurse practitioner which I felt was largely clinical in focus. However, over the 
course of my practicum experiences I experienced how the core competencies dovetail 
together to impact a much more comprehensive approach to advanced nursing practice.  
 My project for MRI of patients with CIEDs provides an example of the use of 
each DNP essential in order to achieve the desired outcome. I used the scientific 
underpinnings of nursing for understanding the theories supporting my project. I used 
leadership and systems thinking to develop a plan to analyze the pilot program. I used the 
literature review to determine best practices currently applied to the problem. An 
understanding of technology and information systems was used to develop templates for 
documentation and data collection, as well as development of the ability to understand 
the computerized technology used to manage cardiac devices. Policy writing became a 
piece of the project as the actual protocol was written to guide the pilot program. The 
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project was designed to improve access to care for the aggregate population of patients 
with cardiac devices. All was done within the advance practice nursing role of the acute 
care nurse practitioner. If one project can touch on each essential core competency, so 
must the ongoing daily practice of the doctorally prepared advanced practice nurse.  
Promoting Quality Improvement 
My practicum experience and capstone project were based on the premise of QI, 
and I became adept in approaching QI issues with the use of the Donabedian framework 
for QI. The Donabedian framework for quality examines structure, process, and 
outcomes. Interactions among providers and patients make up process (Donabedian, 
1978). Structure refers to the environment, equipment, and resources with which the 
providers work (Donabedian, 1978). The actual change in the current and future health 
for a patient/population based on process and structure is the outcome (Donabedian, 
1978). 
In order to achieve the identified quality outcomes, I used information systems 
and technology to enhance implementation of structure component of quality. 
Documentation templates were created to ensure standardized data collection of key 
elements, appropriate patient records were maintained, and billing practices were 
supported. I also worked collaboratively with the information technology team to revise 
the MRI computerized order entry and create a best practice advisory to assist the 
provider in placing the correct order for the correct patient scenario to trigger application 
of the protocol. Additionally, interrogation of cardiac implantable devices was performed 
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and work was started to integrate this technology with the current EHR to create seamless 
transfer of patient information.  
As a result of these efforts for QI and the use of information technology, I became 
more adept in recognizing ways to leverage information technology for the use of 
improved patient outcomes. Once information technology is used and understood, there 
are a multitude of options to leverage the technology for improvement of outcomes. This 
has been a change in my perception from using the EHR as a tool for order entry and 
documentation to a systems level application designed to impact aggregate populations 
and health care in general.  
Improving Health Outcomes 
I was able to serve as a change agent for a new practice which will affect the 
outcomes of patient care through increased access to important diagnostic modalities for 
an aggregate population. One way that I was able to serve as a change agent was through 
increased knowledge in pacemaker design and function and how this technology 
interacted with the design and function of MRI technology. As part of my practicum 
experience, I immersed myself in pacemaker clinics to observe and understand device 
function and its impact on patients. This expertise allowed me to have knowledgeable 
discussions in collaboration with ordering providers regarding practices for MRI on 
pacemaker patients. The relationships I was able to develop with other providers as a 
result of this collaboration increased access to a diagnostic modality for pacemaker 
patients. The initial impact on patient outcome was seen with appropriate device function 
post MRI scan; however, future impact on patient outcomes may come to fruition much 
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later in the continuum of care as early detection of conditions have potential impact on 
treatment options for many patients.  
Informing Health Care Policy   
 As a part of the practicum experience and DNP project, I was the primary author 
for an organizational policy regarding MRI of patients with MR conditional CEID. This 
policy was designed to provide a framework for the application of an evidence-based 
protocol ensuring patient safety, efficacy, and access. This policy was written in 
collaboration with other disciplines and I learned to appreciate the perspective that other 
stakeholders bring to policy formation. 
 The largest learning curve for me in the arena of policy was the ability to analyze 
the financial and business side of policy creation. Performing a financial analysis and 
demonstrating the potential impact of the practice change was most challenging. An 
examination and understanding of the budget allowed for planning in which activities can 
be prioritized to advance the goals of the mission of the program allowing for both 
effectiveness and efficiency. One challenge of the proposed budget was silo budgeting in 
which budgets were managed independently within the overall health system (U.S. 
National Library of Medicine, 2008). The proposed program was a collaborative effort 
between radiology and electrophysiology; however, each department had a separate 
budget. Thus, I found this program had a positive budget impact for one department and a 




 My knowledge and core competencies were expanded through the practicum 
experience and DNP project. Another benefit of the practicum experience was derived 
from placing me in the position to showcase the education and skills of the DNP prepared 
nurse practitioner. As I worked through the DNP curriculum, I was repeatedly placed in 
front of key stakeholders such as nursing administration and medical directors. These 
opportunities allowed me to demonstrate the education, skills, and impact on outcomes 
that the DNP prepared nurse practitioner can offer. This led to a re-evaluation of roles. I 
believe there will be long term benefit to the overall role of advanced practice nurses 
within the organization based on interactions associated with this DNP project and its 
dissemination.  
Challenges and Insights 
The greatest challenge was the administrative task of project approval and 
dissemination. While I am fortunate to work at a Magnet status academic health center 
with a culture that fosters nursing innovation and research, I found that clinical practice at 
one organization with academic undertaking at another was not seamless. I also found 
that working as a nurse practitioner in the internal medicine department while my 
academic endeavors were governed by the nursing education department created 
communication silos that were often difficult to overcome. These experiences were 
educational and allowed me to better understand the healthcare system. Additionally, it 
was insightful regarding the barriers that result in increased time to implement new 
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evidence into practice. This phenomenon was not unique to my clinical and academic 
institutions and is addressed by the IOM and Mannatt report.  
The Institute of Medicine (2010) discussed the future of nursing and 
recommended nurses practice to the fullest extent of their education, achieve higher 
levels of education with seamless progression, be full partners on the healthcare team, 
and improve policy, data collection, and infrastructure. AACN (2016) created the Manatt 
report to address changes in academic nursing to foster the goals put forth by the IOM. In 
order to achieve the overarching goal of embracing a new vision for academic nursing, 
the following recommendations were made for academic nursing and health centers: 1. 
Enhance the clinical practice of academic nursing 2. Partner in preparing future nurses 3. 
Implementation of accountable care 4. Integration of nursing research into clinical 
practice and 6. Create an advocacy agenda.  
Clinical and translational research will be increasingly transdisciplinary as 
healthcare evolves; therefore, creating a culture of interdepartmental, academic, and 
clinical communication and cooperation will be integral to the future progress of 
innovation in healthcare.  
Summary 
Although historically there have been risks associated with MRI of patients with 
pacemakers, recent technological advancements, evidence from randomized controlled 
trials and prospective studies, and expert opinion have begun to change the practice 
paradigm and the presence of a pacemaker is no longer an absolute contraindication to 
MRI as a diagnostic tool. The implementation of an evidence-based, nurse practitioner 
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administered guideline provided the aggregate MR-conditional pacemaker patient 
population with increased access to MRI as a diagnostic tool.  The Iowa Model and 
Donabedian Framework were used to apply MRI and pacemaker principles and evidence 
from clinical trials to the local context. This quality improvement project was an 
evaluation of the evidence-based protocol clinical outcomes using descriptive statistics, 
program fidelity, and clinical indicators to support a formative evaluation. Data collected 
via chart review included device type, MRI site, adherence to manufacturer 
recommendations, pre/post device interrogation parameters, and patient reported 
symptoms. These data were analyzed and revealed no statistically significant changes to 
pacemaker device function or patient-reported symptoms after MRI. The protocol was 
deemed safe and recommended for full adoption of the protocol. This project addressed a 
gap in practice for an aggregate population and supported a change in the practice 
paradigm that will serve to increase access to the diagnostic modality of MRI. There are 
plans in place to disseminate project findings via poster presentation at the organizational 
annual quality symposium. This project provided learning experiences in all of the 
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Policy and Procedure Manual 
MRI Scanning for Patients with MR Conditional Pacemaker 
 
SUBJECT:  MRI Scanning for patients with MR conditional devices   
 
PURPOSE:   To assure consistently safe MRI scanning of MR conditional devices. 
 
DEFINITION: Trained personnel:  
A. ARNP/PA trained in MR conditional device screening, 
management, and possible complications with the skill to 
perform ACLS including CPR, arrhythmia recognition, 
defibrillation, and transcutaneous pacing.  
B. MRI technicians trained in MR conditional devices including 
screening and possible complications.   
C. MR conditional: Under specific conditions there are no known 




A. MRI scanning of MR conditional devices must be a collaborative effort between 
cardiology and radiology.  
 
B.  MRI scanning of MR conditional devices must be performed using a standardized 
protocol following the appropriate conditions of use and manufacturer 
recommendations.  
 
C. Trained personnel:  
1.  Device interrogation and reprogramming will be performed by a device 
trained LIP with ACLS training who will remain with the patient 
throughout the scan until the device has been programmed back to original 
settings and interrogation demonstrates device is properly functioning. 
 









B. Device programming system (Biotronik, Medtronic, Boston Scientific) 
 
C. MR safe cardiac and oxygen saturation monitoring equipment 
 





A. Schedule patient for MRI and coordinate with EP ARNP/PA. 
 
B.  Screen for complete MR conditional system and confirm with manufacturer.  
 1. Biotronik: 1-800-547-0394 
 2. Medtronic: 1-800-925-3368 
 3. Boston Scientific: 1-800-227-3422 
 
C.  Obtain informed consent. 
 
D. Confirm patient identity.  
 
E.  Confirm MRI screening has been performed.  
 
F.  Perform device interrogation and document battery life, lead impedance, sensing, 
and thresholds. 
 
G.  Confirm and document all manufacturer recommendations for device are met.  
 1. Biotronik: 
  a. Cardiology: 
   1.   Complete MR conditional device.  
   2.   Patient is afebrile.  
   3.   Patient height is at least 1.4 meters.  
   4.   The device system has been implanted at least 6 weeks.  
   5.   The device system is implanted in the chest area.  
   6.   Pacing threshold is not above 2.0 V at 0.4 ms.  
   7.   Lead impedance between 200-1500 ohms.  
   8.   Device programmed to MRI mode immediately prior to scan.  
 
  b. Radiology: 
D. MRI system is closed tube, cylindrical magnets, with a static 
field strength of 1.5 T.  
E. Slew rate must not exceed 200 T/m/s.  
F. HF field generated solely by the body coil built into the MRI 
scanner with no additional local emitting coils.  
70 
 
G. MRI performed with patient in dorsal position only.  
H. Overall accumulative time required for imaging must not 
exceed 30 minutes.  
I. Specific absorption rate for the whole body must not exceed 
2.0 W/kg.  
 
 2. Medtronic: 
  a. Cardiology: 
1. Patient implanted with MR conditional device. Only patients 
with a complete MR conditional system may undergo MRI.  
2. Pacemaker and leads have been implanted for 6 weeks.  
3. Atrial and RV thresholds do not exceed 2.0 at 0.4 ms.  
4. Confirm there are no lead extenders/adaptors, no abandoned 
leads, or leads that are not electrically intact.  
5. Device programmed with SureScan mode on prior to entering 
magnet.  
6. Patients with ICD or CRT receive no tachy-therapies and no 
CRT support in SureScan mode.  
   
  b. Radiology: 
1. Horizontal field, cylindrical bore, clinical system for hydrogen 
proton imaging.  
2. MRI power 1.5 T, normal operating mode.  
3. Whole body averaged specific absorption rate (SAR) must be ≤ 
2.0 W/kg 
4. Head SAR must be ≤ 3.2 W/kg 
5. Maximum spatial gradient ≤ 20 T/m  
6. Gradient systems with a maximum gradient slew rate 
performance per axis of ≤ 200 T/m/s 
 
 3. Boston Scientific: 
  a. Cardiology: 
1. Patient implanted with MR conditional device.  
2. Device has been implanted for a minimum of 6 weeks without 
lead or           other surgical revision within the 6-week time 
period.  
3. Generator implantation in the left or right pectoral region.  
4. No abandoned leads, lead adapters, or extenders.  
5. No evidence of fractured lead or compromised generator/lead 
integrity, damage to the generator seal plug or rings.  
6. Pacing threshold ≤ 2.0V in pace-dependent patients. 
7. Bipolar pacing operation or pacing OFF. 
8. Patient is afebrile. 
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9. Pulse generator programmed to MRI protection mode during 
scan. 
 
  b. Radiology:  
1. Magnet strength 1.5 T with radiofrequency of approximately 
64 MHz, and spatial gradient no greater than 50 T/m over 
pacing system.  
2. Horizontal, H proton, closed bore scanners only.  
3. Specific Absorption Rate (SAR) limits: whole body averaged ≤ 
4.0 W/kg, Head ≤ 3.2 W/kg. 
4. Maximum specified gradient slew rate ≤ 200 T/m/s per axis.  
5. No local transmit only coils or local transmit/receive coils 
placed directly over the pacing system. The use of receive only 
coils is not restricted.  
6. Patient in supine or prone position only.  
    
H.  Program the device to MRI scan mode.  
 
J. Connect patient to telemetry and SpO2 monitor for continuous monitoring until 
baseline or clinically appropriate device settings have been restored. 
 
J.  Perform MRI scan as ordered with 1.5 T MRI scanner adhering to manufacturer 
specifications. 
  
K.   Assess patient for any symptoms such as warmth/heating or vibration at the 
pacemaker site, hemodynamic changes, lightheadedness, dizziness, shortness of 
breath, or palpitations.  
 
L.  Upon completion of MRI scan, reprogram device to original settings.  
 
M.  Perform device interrogation including battery life, lead impedance, sensing, and 
thresholds. If significant changes (i.e. threshold change of greater than 0.5 V at 
0.4 ms) are noted document and consult electrophysiologist.  
 
N.  All documentation should be completed in MRI/Pacemaker documentation 
template in EPIC.  
 
RELATED STANDARDS: 
American Heart Association 
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roMRI_Manual.pdf 
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Appendix C: Documentation Template for Data Collection 
Documentation Template for MRI of MR Conditional Pacemakers 
 
Date of Service: *** 
 
The patient is a @AGE@ y.o. @SEX@ who is implanted with an MRI conditional 
pacemaker. Recommended to undergo a *** MRI by Dr. *** to evaluate ***. 
Informed consent was obtained for device re-programming necessary for MRI 
scanning. 
 
IMPLANTED MATERIALS:  
Dual/single*** Chamber Pacemaker implanted for *** 
 
Device verified as MRI conditional with company:  *** device verified as MRI 
conditional.  
 
Device interrogation reveals the following: 
Presenting rhythm:  *** 
 
Paced and Sensed: Atrial: ***% paced; Ventricular: ***% paced 
• Is patient pacemaker dependent?  *** 
 
Current Programming: 
Brady parameters: Pacing mode ***, lower rate limit *** beats per minute.  
 
Measurements: 
Battery:   
 
Right atrial lead:  Intrinsic P-waves measured at: *** mV. Lead Impedance: *** 
ohms. Pacing threshold: *** V @ 0.4 ms.  
Programmed: 3.5 V @ 0.4 ms; sensitivity: 0.25 mV.  Sense polarity:  Bipole 
 
Right ventricular lead:  Intrinsic R-waves measured at: *** mV. Lead 
Impedance: *** ohms. Pacing threshold: *** V @ 0.4 ms.  
Programmed: 3.5 V @ 0.4 ms; sensitivity: 0.6 mV.  Sense polarity:  Bipole 
 
Left ventricular lead:  Intrinsic R-waves measured at: *** mV. Lead Impedance: 
*** ohms. Pacing threshold: *** V @ 0.4 ms.  
Programmed: 3.5 V @ 0.4 ms; sensitivity: 1.0 mV.  Sense polarity: *** 
 
***Complete next section according to device manufacturer*** 
 
Biotronik PRE-SCREENING CRITERIA: 
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The device consists only of one or more leads and a pacemaker or ICD which 
are each separately labeled MR conditional and can in combination constitute an 
MR conditional device system. 
• There are no other devices in the patient's body?   *** MRI screening done?  
*** 
• Abandoned leads?  *** 
• Lead adaptors?  *** 
• Lead Extensions?  *** 
• Is the patient afebrile?  *** 
• Is the patient's height at least 1.4 meters (140 cm or 4'7")? *** 
• Has the device been implanted at least 6 weeks?  *** 
• Is the device system in the patient's chest?  *** 
• Is the ascertained pacing threshold 2.0 V @0.4 ms or lower?  *** 
• Is the ascertained lead impedance between 200 and 1500 ohms(Ω).?  *** 
 
 
Medtronic PRE-SCREENING CRITERIA: 
It was verified that: 
• There are no other devices in the patient's body?   *** MRI screening done?  
*** 
• Abandoned leads?  *** 
• Lead adaptors?  *** 
• Lead Extensions?  *** 
• SureScan pacemaker system has been implanted in the left or right pectoral 
region for a minimum of 6 weeks*** 
• Is the ascertained pacing threshold 2.0 V @0.4 ms or lower?  *** 
• Is the ascertained lead impedance between 200 and 1500 ohms(Ω).?  *** 
 
 
Boston Scientific PRE-SCREENING CRITERIA: 
It was verified that: 
• There are no other devices in the patient's body?   *** MRI screening done?  
*** 
• Abandoned leads?  *** 
• Lead adaptors?  *** 
• Lead Extensions?  *** 
• The pacemaker system has been implanted in the left or right pectoral region 
for a minimum of 6 weeks without lead or other surgical revision within the 6-
week time period*** 
• Is the ascertained pacing threshold 2.0 V @0.4 ms or lower?  *** 
• There is no evidence of lead fracture or compromised generator/lead 
integrity.?  *** 
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• Bipolar pacing operation is OFF? *** 
• The patient is afebrile? *** 
• MRI Mode timeout used? *** time out will occur at *** 
 
 
MRI SCANNER:  
Verified with MRI Technologist: *** 
• Is MRI scanner is closed tube, cylindrical magnets and a static magnetic field 
of 1.5T?  *** 
• Is the slew rate of the MRI scanner's gradient fields 200 T/m/s per axis or 




The test showed a normally functioning generator and atrial and ventricular 
system with appropriate lead parameters for performing an MRI. The device 
manufacturer recommendations have been met. The device has been 
reprogrammed to MRI mode for scan.  
 
The patient was continuously monitored throughout the scan with telemetry and 




Post MRI Scan: 
• The device was reprogrammed from MRI mode to documented pre-scan 
programming? *** 
• Battery: *** 
• Lead impedance remained 200 and 1500 ohms(Ω).?  *** 







Appendix D: Project Poster for Dissemination 
 
 
